CERE
Ensign Peak Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-66,655
| Closed | -$2.83M | – | 1762 |
|
|
2023
Q4 | $2.83M | Buy |
66,655
+37,365
| +128% | +$1.58M | 0.01% | 783 |
|
|
2023
Q3 | $639K | Hold |
29,290
| – | – | ﹤0.01% | 1497 |
|
|
2023
Q2 | $931K | Hold |
29,290
| – | – | ﹤0.01% | 1320 |
|
|
2023
Q1 | $714K | Hold |
29,290
| – | – | ﹤0.01% | 1498 |
|
|
2022
Q4 | $924K | Buy |
29,290
+12,100
| +70% | +$382K | ﹤0.01% | 1223 |
|
|
2022
Q3 | $486K | Buy |
17,190
+5,540
| +48% | +$157K | ﹤0.01% | 1472 |
|
|
2022
Q2 | $308K | Sell |
11,650
-71,159
| -86% | -$1.88M | ﹤0.01% | 1670 |
|
|
2022
Q1 | $2.9M | Hold |
82,809
| – | – | 0.01% | 737 |
|
|
2021
Q4 | $2.69M | Buy |
82,809
+11,650
| +16% | +$378K | 0.01% | 861 |
|
|
2021
Q3 | $2.1M | Hold |
71,159
| – | – | ﹤0.01% | 1098 |
|
|
2021
Q2 | $1.82M | Hold |
71,159
| – | – | ﹤0.01% | 1177 |
|
|
2021
Q1 | $977K | Buy |
+71,159
| New | +$977K | ﹤0.01% | 1433 |
|